Key result
Combining hs-CRP and logistic EuroSCORE modestly predicts one-year mortality in TAVI patients.
Why the study?
The clinical value of biomarkers to identify TAVI patients at high risk for adverse outcome and whether combining biomarkers with clinical risk scores improves prognostic information was assessed.
Does the combination of high-sensitivity C-reactive protein (hs-CRP) and logistic EuroSCORE improve risk stratification for one-year mortality in patients undergoing TAVI?
Observational (n=683)
Does the combination of high-sensitivity C-reactive protein (hs-CRP) and logistic EuroSCORE improve risk stratification for one-year mortality in patients undergoing TAVI?
Answers are grounded in this paper and cite their sources.
The addition of pre-procedural hs-CRP to the logistic EuroSCORE improves the prediction of one-year all-cause mortality in patients undergoing TAVI.
AIMS: The aim of this study was to assess the clinical value of biomarkers to identify TAVI patients at high risk for adverse outcome, to assess whether these biomarkers provide prognostic information beyond that of established clinical risk scores, and to assess whether a combined multi-marker strategy can improve clinical decision making. METHODS AND RESULTS: In 683 TAVI patients, biomarkers reflecting various pathophysiologic systems were measured before TAVI. The primary endpoint was one-year all-cause mortality. Other outcomes were recorded according to the VARC-2 criteria. Thirty-day and one-year mortality was 2.9% and 12.0%, respectively. Non-survivors at one year had higher risk scores and increased median biomarker levels. Logistic EuroSCORE in combination with hs-CRP had the highest predictive value for 30-day (AUC 0.740 [95% CI: 0.667-0.812], p=0.1117) and one-year mortality (AUC 0.631 [95% CI: 0.569-0.693], p=0.0403). In multivariate regression analysis, logistic EuroSCORE in combination with hs-CRP showed the strongest association with one-year mortality. Combinations of increasing medians of logistic EuroSCORE results and hs-CRP levels allowed the stratification of the TAVI patients into subgroups with one-year mortality rates ranging from 6.6% up to 18.2%. CONCLUSIONS: hs-CRP alongside the logistic EuroSCORE was an independent predictor of one-year all-cause mortality in TAVI patients. A combination of both might help to predict procedural risk and outcome better.
No takes yet. Share an insight, caveat, or question.
Stundl et al. (2018) conducted an observational in Patients undergoing TAVI (n=683). Combination of high-sensitivity C-reactive protein (hs-CRP) with logistic EuroSCORE was evaluated on one-year all-cause mortality (AUC 0.631, 95% CI 0.569-0.693, p=0.0403). The combination of hs-CRP with logistic EuroSCORE predicted one-year all-cause mortality in patients undergoing TAVI.
Synapse has enriched 10 related papers. Consider them for comparative context: